List of insiders holdings for MACROGENICS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | BIOTECH TARGET N V BB BIOTECH AG 10% Owner |
2025-02-14 14:39:02 | 9,929,963 0 |
9,929,963 | Form 13G |
| 2 | ORONSKY ARNOLD L Director |
2014-02-18 16:03:27 | 0 1,708,716 |
1,708,716 | Form 4 |
| 3 | INTERWEST PARTNERS VIII LP InterWest Management Partners VIII LLC INTERWEST INVESTORS VIII L P INTERWEST INVESTORS Q VIII LP CASH HARVEY B GIANOS PHILIP T Kliman Gilbert H HEDRICK W SCOTT Holmes W Stephen 10% Owner |
2015-02-13 06:18:59 | 1,282,303 0 |
1,282,303 | Form 13G |
| 4 | Koenig Scott President and CEO |
2025-02-19 16:28:50 | 819,745 0 |
819,745 | Form 4 |
| 5 | Karrels James SVP, CFO and Secretary |
2025-02-19 16:29:59 | 201,800 0 |
201,800 | Form 4 |
| 6 | Bonvini Ezio Sr VP, Research & CSO |
2025-02-19 16:31:12 | 141,079 0 |
141,079 | Form 4 |
| 7 | Wigginton Jon Marc Sr VP, Clinical Dev. & CMO |
2020-02-24 16:46:33 | 100,000 0 |
100,000 | Form 4 |
| 8 | Stein Kathryn E SVP, Product Dev. & Regulatory |
2016-01-11 13:39:46 | 95,555 0 |
95,555 | Form 4 |
| 9 | Risser Eric Blasius Chief Operating Officer |
2025-02-19 16:24:26 | 72,654 0 |
72,654 | Form 4 |
| 10 | Chhabra Meenu Director |
2024-05-23 17:18:17 | 56,577 0 |
56,577 | Form 4 |
| 11 | Eck Stephen L. Chief Medical Officer |
2025-02-19 16:20:46 | 46,042 0 |
46,042 | Form 4 |
| 12 | Spitznagel Thomas Sr VP, Technical Ops |
2025-02-19 16:22:09 | 34,734 0 |
34,734 | Form 4 |
| 13 | ALTA BIOPHARMA PARTNERS III LP ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC 10% Owner |
2016-02-12 17:24:27 | 27,630 0 |
27,630 | Form 13G |
| 14 | Peters Jeffrey Stuart Senior VP and General Counsel |
2025-02-19 16:25:47 | 27,043 0 |
27,043 | Form 4 |
| 15 | HURWITZ EDWARD Director |
2024-05-23 17:16:25 | 23,000 0 |
23,000 | Form 4 |
| 16 | SIEGEL JAY PHILIP Director |
2024-05-23 17:18:36 | 23,000 0 |
23,000 | Form 4 |
| 17 | O'Brien Federica F. Director |
2024-05-23 17:17:58 | 23,000 0 |
23,000 | Form 4 |
| 18 | Ferrante Karen Jean Director |
2024-05-23 17:17:13 | 23,000 0 |
23,000 | Form 4 |
| 19 | STUMP DAVID C Director |
2024-05-23 17:16:58 | 23,000 0 |
23,000 | Form 4 |
| 20 | HEIDEN WILLIAM K Director |
2024-05-23 17:16:44 | 23,000 0 |
23,000 | Form 4 |
| 21 | Jackson Scott Thomas Director |
2024-05-23 17:16:03 | 23,000 0 |
23,000 | Form 4 |
| 22 | Cilinski Lynn VP, Controller and Treasurer |
2024-02-20 18:04:45 | 19,545 0 |
19,545 | Form 4 |
| 23 | SARAN ATUL SVP & General Counsel |
2017-05-02 12:58:29 | 16,986 0 |
16,986 | Form 4 |
| 24 | Liu Margaret Director |
2024-05-24 17:08:21 | 16,500 0 |
16,500 | Form 4/A |
| 25 | Stewart Stanford John V P, Clinical Oncology |
2013-10-11 16:46:03 | 15,979 0 |
15,979 | Form 4 |
| 26 | Galbraith Kenneth Director |
2021-05-17 21:20:23 | 15,000 0 |
15,000 | Form 4 |
| 27 | Costa Paulo F Director |
2021-05-17 21:17:27 | 15,000 0 |
15,000 | Form 4 |
| 28 | Nadav Eran Director |
2013-10-11 16:54:29 | 13,849 0 |
13,849 | Form 4 |
| 29 | Smith Beth Ann VP, Controller & Treasurer |
2025-02-19 16:23:17 | 10,627 0 |
10,627 | Form 4 |
| 30 | Fust Matthew K Director |
2019-05-20 17:47:34 | 10,000 0 |
10,000 | Form 4 |
| 31 | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G Former 10% Owner |
2015-02-13 12:35:06 | 0 0 |
0 | Form 13G |